Shares of Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $0.39 and last traded at $0.39, with a volume of 2250 shares changing hands. The stock had previously closed at $0.46. Sino Biopharmaceutical Stock Down 15.6 % The stock’s […]
Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Rating)’s stock price traded down 6.1% during mid-day trading on Tuesday . The company traded as low as $0.46 and last traded at $0.46. 3,750 shares changed hands during mid-day trading, a decline of 16% from the average session volume of 4,490 shares. The stock had previously closed at […]
Investment will enable pHion to progress its lead program into the clinic Transaction builds on invoX's initial investment in 2021 invoX Pharma Limited ("invoX")a U.K.-based wholly-owned subsidiary
invoX Pharma increases investment in pHion Therapeutics to further develop next generation of mRNA vaccinesInvestment will enable pHion to progress its lead program into the clinicTransaction builds on invoX’s initial investment in 2021 LONDON, United Kingdom, June, 1, 2023: invoX Pharma Limited (“i.
Investment will enable pHion to progress its lead program into the clinicTransaction builds on invoX’s initial investment in 2021LONDON (BUSINESS WIRE) invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline.